Technology
Health
Pharmaceutical
MYOS RENS
$1.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.00 (0.16%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours
Why Robinhood?
You can buy or sell MYOS RENS and other stocks, options, ETFs, and crypto commission-free!
About MYOS
MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies aimed at maintaining or improving the health and performance of muscle tissue. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. Read More The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
Employees
12
Headquarters
Cedar Knolls, New Jersey
Founded
2007
Market Cap
14.03M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
5.31K
High Today
$1.56
Low Today
$1.56
Open Price
$1.56
Volume
236.00
52 Week High
$2.02
52 Week Low
$1.04
Collections
Technology
Health
Pharmaceutical
2016 IPO
US
North America
MYOS News
Price Paid on Robinhood
18% Lower
Right Now
52 Week Low
$1.04
Average Price Paid
$1.87
52 Week High
$2.50
MYOS Earnings
-$0.19
-$0.13
-$0.06
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.12 per share
Actual
-$0.13 per share